HAEMATO Owners | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | HAEMATO AG

HAEMATO AG | Ownership

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Baring Asset Management Ltd.

548,540

2.5%

-43,832

0.05%

10/31/2017

Raymond James Asset Management International SA

154,325

0.7%

84,325

0.48%

12/31/2016

Norges Bank Investment Management

45,121

0.21%

3,582

12/31/2017

View Profile

Address	Lilienthalstraße 5c Schönefeld Brandenburg 12529 Germany
Employees	-
Website	http://haemato.de
Updated	07/08/2019
Haemato AG engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes therapies for cancer, HIV, rheumatology, and other chronic diseases. It also consists of products for the privately financed market for aesthetic treatments.